Usefulness of the MESH score in a European hepatocellular carcinoma cohort

Table 3 Comparison of performances of each scoring systems in patients treated by surgery/radiofrequency ablation

Score	Discriminatory ability linear trend test		Homogeneity likelihood ratio test		Akaike Information Criterion	C-index (95%CI)
	LT (χ²)	P value	LR (χ²)	P value
MESH	21.5588	< 0.0001	23.3342	< 0.0001	346.508	0.719
BCLC	15.5560	< 0.0001	12.4538	0.0020	359.388	0.644
HKLC	5.9647	0.0146	18.9510	0.0020	358.891	0.629
CLIP	9.9391	0.0016	13.1460	0.0003	356.696	0.642
NIACE	19.1701	< 0.0001	23.1937	< 0.0001	346.648	0.672

MESH: Model to estimate survival for HCC; BCLC: Barcelona Clinic Liver Cancer; HKLC: Hong Kong Liver Cancer; CLIP: Cancer of the Liver Italian Program; NIACE: Tumor Nodularity, Infiltrative nature of the tumor, serum Alpha-fetoprotein level, Child-Pugh stage, Eastern Cooperative Oncology Group Performance Status.